We are live on ! Find out more
MWVC

Morgens Waterfall Vintiadis & Co Portfolio holdings

AUM $81.2M
1-Year Est. Return 86.87%
This Fund
S&P 500
This Quarter Est. Return
+7.35%
1 Year Est. Return
+86.87%
3 Year Est. Return
+484.3%
5 Year Est. Return
+875.12%
10 Year Est. Return
+12,893.79%
AUM
$159M
AUM Growth
+$3.07M
Cap. Flow
-$2.64M
Cap. Flow %
-1.66%
Top 10 Hldgs %
41.49%
Holding
61
New
16
Increased
8
Reduced
5
Closed
18

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$7.51M
2
XLNX
Xilinx Inc
XLNX
+$4.51M
3
CAVM
Cavium, Inc.
CAVM
+$4.42M
4
GS icon
Goldman Sachs
GS
+$4.28M
5
AAPL icon
Apple
AAPL
+$4.22M

Sector Composition

Rank Sector Weight
1 Healthcare 24.73%
2 Technology 20.89%
3 Financials 15.53%
4 Communication Services 10.21%
5 Consumer Discretionary 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$163B
$8.99M 5.66%
76,800
-18,200
-19% -$1.99M
META icon
2
Meta Platforms (Facebook)
META
$1.37T
$7.98M 5.02%
93,000
+4,000
+4% +$327K
JPM icon
3
JPMorgan Chase
JPM
$933B
$7.79M 4.9%
+115,000
New +$7.51M
CRDF icon
4
Cardiff Oncology
CRDF
$66.2M
$7.76M 4.89%
10,625
+2,292
+28% +$1.63M
FCH
5
DELISTED
Felcor Lodging Trust
FCH
$7.71M 4.85%
780,000
+20,000
+3% +$219K
AAPL icon
6
Apple
AAPL
$4.9T
$5.89M 3.71%
188,000
+132,000
+236% +$4.22M
NXPI icon
7
NXP Semiconductors
NXPI
$61.8B
$5.89M 3.71%
60,000
+1,000
+2% +$103K
AMAG
8
DELISTED
AMAG Pharmaceuticals
AMAG
$4.83M 3.04%
70,000
MA icon
9
Mastercard
MA
$510B
$4.67M 2.94%
50,000
XLNX
10
DELISTED
Xilinx Inc
XLNX
$4.42M 2.78%
+100,000
New +$4.51M
GS icon
11
Goldman Sachs
GS
$302B
$4.38M 2.76%
+21,000
New +$4.28M
CAVM
12
DELISTED
Cavium, Inc.
CAVM
$4.33M 2.73%
+63,000
New +$4.42M
CELG
13
DELISTED
Celgene Corp
CELG
$4.05M 2.55%
35,000
LOW icon
14
Lowe's Companies
LOW
$118B
$4.02M 2.53%
60,000
QRVO icon
15
Qorvo
QRVO
$8.01B
$4.01M 2.53%
50,000
-8,500
-15% -$659K
ZBH icon
16
Zimmer Biomet
ZBH
$18.4B
$3.93M 2.47%
+37,080
New +$4.1M
PFE icon
17
Pfizer
PFE
$142B
$3.86M 2.43%
121,210
-52,700
-30% -$1.72M
ON icon
18
ON Semiconductor
ON
$32.6B
$3.59M 2.26%
307,000
+47,000
+18% +$577K
TOL icon
19
Toll Brothers
TOL
$14B
$3.34M 2.1%
+87,500
New +$3.28M
PPLI
20
People Inc
PPLI
$3.08B
$3.27M 2.05%
+229,412
New +$3.04M
ATML
21
DELISTED
ATMEL CORP
ATML
$3.2M 2.02%
+325,000
New +$2.86M
AGN
22
DELISTED
Allergan plc
AGN
$3.19M 2%
10,500
BIIB icon
23
Biogen
BIIB
$30.7B
$3.15M 1.98%
+7,800
New +$3.13M
CFG icon
24
Citizens Financial Group
CFG
$30.3B
$3.14M 1.98%
+115,000
New +$3.05M
SWKS icon
25
Skyworks Solutions
SWKS
$9.4B
$3.12M 1.97%
30,000
+13,000
+76% +$1.32M

Similar funds

Morgens Waterfall Vintiadis & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Morgens Waterfall Vintiadis & Co held 61 positions worth $159M, up 2% from $156M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Morgens Waterfall Vintiadis & Co's Q2 2015 filing shows 16 new, 8 increased, 5 reduced and 18 closed positions. Its largest new stake was JPMorgan Chase: 115,000 shares worth $7.79M. The largest sale was Insulet, an estimated $7.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

  • Morgens Waterfall Vintiadis & Co's largest Q2 2015 buy was JPMorgan Chase: 115,000 shares worth $7.79M.
  • Morgens Waterfall Vintiadis & Co added most to Apple in Q2 2015, an estimated $4.22M increase.
  • Morgens Waterfall Vintiadis & Co's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.99M.
  • Morgens Waterfall Vintiadis & Co fully exited Insulet in Q2 2015, selling an estimated $7.2M.
  • Morgens Waterfall Vintiadis & Co's ten largest holdings make up 41% of its $159M portfolio in Q2 2015.
  • Morgens Waterfall Vintiadis & Co opened 16 new positions and closed 18 in Q2 2015.
  • Morgens Waterfall Vintiadis & Co's portfolio value rose 2% quarter-over-quarter to $159M.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q2 2015, filed 3 Aug 2015.